Evidence map›Paper›PMID 28163905›Full record

ReviewF1000Research2017

STAT5 and CD4

David L Owen, Michael A Farrar

Abstract readReview
In one paragraph

Review in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Nanomaterials-Based Immunotherapy for Atherosclerosis.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. CD4Journal of the American Heart Association · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David L OwenCenter for Immunology, Masonic Cancer Center, and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.
Michael A FarrarCenter for Immunology, Masonic Cancer Center, and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
IMMUNOLOGY TRAINING PROGRAMT32AI007313 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Carla Rothlin · 1989 to 2026
$5.7M
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic LeukemiaR01CA151845 · NCI · UNIVERSITY OF MINNESOTA · PI FARRAR, MICHAEL ARCHIBALD · 2011 to 2015
$1.5M
Transponson-based screens for genes involved in acute lymphoblastic LeukemiaR01CA154998 · NCI · UNIVERSITY OF MINNESOTA · PI FARRAR, MICHAEL ARCHIBALD · 2011 to 2015
$1.5M
(PQB3) CD4 T cell response to BCR-ABL-positive LeukemiaR01CA185062 · NCI · UNIVERSITY OF MINNESOTA · PI FARRAR, MICHAEL ARCHIBALD · 2014 to 2017
$1.2M
TNF Receptor Superfamily Signaling in Immune ToleranceR56AI113138 · NIAID · UNIVERSITY OF MINNESOTA · PI FARRAR, MICHAEL ARCHIBALD · 2014 to 2014
$376k
NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA151845NCI NIH HHS R01 CA154998NCI NIH HHS R01 CA185062NIAID NIH HHS R56 AI113138NIAID NIH HHS T32 AI007313
6 · The paper itself

Abstract

STAT5 plays a critical role in the development and function of many cell types. Here, we review the role of STAT5 in the development of T lymphocytes in the thymus and its subsequent role in the differentiation of distinct CD4

Indexed as

STAT5T-cell developmentT-cell function

Identifiers

PMID28163905
PMCPMC5247784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.